elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q42910816-212CE331-B93B-48EA-8D4D-055EA9D5FECF
Q42910816-212CE331-B93B-48EA-8D4D-055EA9D5FECF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42910816-212CE331-B93B-48EA-8D4D-055EA9D5FECF
Competing risk survival analysis in patients with symptomatic Waldenström macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy.
P2860
Q42910816-212CE331-B93B-48EA-8D4D-055EA9D5FECF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42910816-212CE331-B93B-48EA-8D4D-055EA9D5FECF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bea7f0286e48f3dbcf00920803b54549170502cc
P2860
Comorbidity and competing risks for mortality in men with prostate cancer.